Sponsors

RECENT NEWS

Protocols to monitor emicizumab with greater confidence

Diagnostica Stago has developed an automated test set-up to enable monitoring of the new, highly-active haemophilia drug emicizumab. The new protocol also eliminates any carry-over concerns.

Neutrophil reactivity and granularity: a matter of intensity

Sysmex’s haematological inflammation parameters support early diagnosis so that targeted treatment can be started, changed or modified. Monitoring patients with inflammatory diseases and the success of their therapy helps to avoid antibiotic overuse.

Digital pathology image analysis algorithms in breast cancer

Roche has announced the CE-IVD launch of its automated digital pathology algorithms uPath HER2 (4B5) image analysis and uPath Dual ISH image analysis for breast cancer to help determine the best treatment strategy for each patient.

Annual SHOT Report 2019: ADU highlights webinar

The SHOT team will host its first webinar of 2021 on 28 January, 1400–1500 GMT, and cover the Avoidable, Delayed or Under/Overtransfusion (ADU) chapter of the Annual SHOT Report 2019. Click on this story for the link to register.

Realising the full potential of AI-enabled digital pathology

Proscia, a provider of digital and computational pathology solutions, has announced that Laboratorium Pathologie Oost-Nederland (LabPON), the first laboratory in the world to 100% digital pathology diagnosis, will deploy its Concentriq platform.

Immunotherapy in resistant cancer: from the bench to the clinic

A new textbook entitled ‘Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives’ explains immunotherapies for different types of cancer, helping users carry out research or create alternatives for drug development.

Branching out: DNA advances in degenerative disease treatments

New research on the structure and dynamics of a branched form of DNA called a three-way junction could lead to more effectively targeted treatments for degenerative disorders like Huntington’s disease.

Blood test to support challenging decision-making in prostate cancer

Proteomedix, the Swiss cancer diagnostics company, has announced that the results of PROPOSe, a prospective multicentre study of Proclarix in clinical routine use, have been published in European Urology Oncology.

Deadly parasites create unique cellular structures to survive

Scientists have solved a key parasitic puzzle, revealing the unique and complex structures toxoplasmosis and malaria parasites make in order to survive in different hosts.

Global Image of the Year Award: a call for entries

Following the success of the first Global Image of the Year Life Science Light Microscopy Award, Olympus has launched its second annual Global Image of the Year Award to recognise the best in life science imaging.

Progress in unbiased, quantitative true single-cell proteomics

Bruker Corporation and Evosep have announced major progress in high-sensitivity, quantitative true single-cell proteomics, using a modified timsTOF Pro mass spectrometer connected to an Evosep One low-flow chromatography system.

Evolutionary Diversity as a Source for Anticancer Molecules

A new textbook entitled Evolutionary Diversity as a Source for Anticancer Molecules discusses evolutionary diversity as a source for anticancer agents derived from bacteria, algae, bryophytes, pteridophytes, and gymnosperms.

Happy New Year from the team at Step Communications

The past year has proved challenging for readers, contributors and commercial colleagues alike; however, the team responsible for publication of Pathology in Practice looks forward with some confidence to a better 2021.

Debra Padgett: IBMS President-Elect

Debra Padgett has been confirmed as the IBMS President-Elect, a position that took effect from 1 January 2021. She will work with the current President, Allan Wilson, and will succeed him as President on 1 January 2022.

Gambica Young Talent of the Year Award

Joshua Walker, Export Manager at Priorclave, has won the Gambica 2020 Young Talent of the Year Award.

New test for the detection of synovial sarcoma

ProPath has announced the addition of SS18-SSX to its antibody library. It is a fusion-specific antibody that is highly sensitive (95%) and specific (100%) for the detection of synovial sarcoma.

Method comparisons: an article series

In the third article in his series on method comparisons, now published in the December issue, Stephen MacDonald focuses on what differences are expected and acceptable, and what other factors need further investigation.

Thank you, and best wishes for Xmas and 2021

The team responsible for publication of Pathology in Practice wishes to acknowledge the support received in difficult times over the past months from readers, contributors and commercial colleagues.

Surveillance of AMR diseases could be more challenging outside the EU

In a new report from the Microbiology Society, experts from around the UK explain the desperate need for long-term and ambitious funding for surveillance and research into antimicrobial resistance (AMR).

Biomedical Science Industry Handbook: reflecting on IVD expertise

The Biomedical Science Industry Handbook 2021 is now available as a hard copy and in digital format. It provides comprehensive information on the full range of products and services from the in vitro diagnostics (IVD) industry.

Latest Issues

IHC technical issues masterclass

UK NEQAS CPT, The Haylofts, Newcastle
13 August, 2025

37th European Congress of Pathology

ACV, Vienna, Austria
6 -10 September, 2025

IBMS Congress

The International Convention Centre (ICC), Birmingham
22-25 September, 2025